Latest S-1 registration statements

Virpax Pharmaceuticals is offering up to 16,849,200 shares of common stock and pre-funded warrants to raise capital for clinical trials, working capital, and general corporate purposes.

Mustang Bio plans a public offering of common stock and warrants to fund its CAR T therapy development for hematologic malignancies and solid tumors.

Stardust Power aims to bolster its financial position by offering shares of common stock and warrants, targeting proceeds of $12.5 million.

Armlogi Holding Corp. has filed an amendment to its Form S-1 registration statement for the resale of up to 13,168,147 shares of common stock by YA II PN, LTD.

NusaTrip Inc. has filed an amendment to its Form S-1 registration statement for its initial public offering, planning to list on the Nasdaq Capital Market under the symbol NUTR.

Shuttle Pharmaceuticals is registering for resale 1,464,268 shares of common stock underlying convertible notes and 329,461 shares of common stock issuable upon exercise of warrants, all issued in a recent private placement.

ReShape Lifesciences has filed an amendment to its S-1 registration statement, detailing the potential resale of up to 2,112,072 shares of common stock by a selling stockholder.

Hennessy Capital Investment Corp. VII, a newly formed blank check company, has filed an amendment to its registration statement for a $175 million initial public offering, focusing on acquisitions in the industrial technology and energy transition sectors.

Aclarion, Inc. has filed a registration statement to offer up to $8.1 million in additional securities, including common stock and warrants.

Nano Nuclear Energy is registering for resale up to 2,500,002 shares of its common stock and an equal number of shares issuable upon exercise of warrants, totaling approximately $128.8 million.

Thunder Power Holdings seeks to register the resale of up to $100 million in common stock by Westwood Capital Group and 8,570 shares by Benjamin Securities.

Enveric Biosciences is offering shares of common stock and accompanying warrants, or pre-funded warrants and accompanying warrants, to raise capital for product development and general corporate purposes.

Silexion Therapeutics launches a best-efforts offering to raise up to $5 million for advancing its RNAi-based cancer therapies, including SIL-204B for pancreatic cancer.

Northann Corp. has filed an amendment to its Form S-1 registration statement to allow selling stockholders to resell up to 30,084,400 shares of common stock acquired through various acquisitions and private placements.

Go Green Global Technologies Corp. has entered into a promissory note agreement with AJB Capital Investments LLC for a $90,000 loan, which includes conversion rights under certain conditions.

Hepion Pharmaceuticals plans to offer shares of common stock, pre-funded warrants, and common stock purchase warrants in a reasonable best efforts offering.

Adagio Medical Holdings seeks to register the resale of up to 67.9 million common shares by existing stockholders, including shares from PIPE investors, convertible noteholders, and the Sponsor.

Scienture Holdings is registering the resale of up to 4.3 million shares of common stock by selling stockholders, including shares related to ELOC and Securities Purchase Agreements.

Hyperscale Data, Inc. files an amendment to its registration statement for the potential resale of up to 1,500,000 shares of its 13.00% Series D Cumulative Redeemable Perpetual Preferred Stock by Orion Equity Partners LLC.

Adagio Medical Holdings seeks to register the resale of shares by selling stockholders following its recent business combination, involving convertible notes and warrants.

Palvella Therapeutics files an amendment to its registration statement for the potential resale of up to 5,634,504 shares of its common stock by selling stockholders.

Silexion Therapeutics is launching a best-efforts offering to raise up to $5 million for advancing its RNAi-based cancer therapies.

Cosmos Health Inc. amends its S-1 filing, outlining a proposed $7.5 million offering and providing updates on its financial condition and recent transactions.

FreeCast, Inc. files an amendment to its S-1 registration statement for a direct listing of its Class A common stock on the Nasdaq Capital Market, involving the resale of up to 18,006,057 shares by existing shareholders.

Toppoint Holdings Inc. is proceeding with its IPO, offering 2,500,000 shares of common stock with an estimated price range of $4.00 to $6.00 per share.

Wellgistics Health, a holding company focused on pharmaceuticals and healthcare services, has filed an amendment to its Form S-1 registration statement for an initial public offering of 900,000 shares of common stock, with plans to list on the Nasdaq Capital Market under the symbol WGRX.

Brag House Holdings, Inc. files an amendment to its S-1 registration statement, detailing its business model, financial data, and growth prospects as it prepares for its initial public offering.

Stellar V Capital Corp., a blank check company, has filed an amendment to its S-1 registration statement for a $150 million initial public offering aimed at pursuing a business combination.

AleAnna, Inc. seeks to raise capital through the potential exercise of public warrants, while navigating a stock price below the exercise threshold and inherent market risks.

Lennar Corporation is set to spin off its land asset management business, Millrose Properties, into an independent, publicly traded REIT through a taxable distribution of shares to existing Lennar stockholders.